Yoskowitz Marc J 4
4 · Mereo BioPharma Group plc · Filed Feb 6, 2025
Insider Transaction Report
Form 4
Yoskowitz Marc J
Director
Transactions
- Award
Share Options (Right to buy)
2025-02-05+55,000→ 55,000 totalExercise: $3.16Exp: 2035-02-05→ American Depositary Shares (55,000 underlying) - Award
Deferred Restricted Stock Units
2025-02-05+13,719→ 13,719 total→ American Depository Shares (13,719 underlying)
Footnotes (3)
- [F1]Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date
- [F2]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer
- [F3]Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.